Skip to main content

Leidos’s Q1 Earnings Call: Our Top 5 Analyst Questions

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

LDOS Cover Image

Leidos reported first quarter results that exceeded Wall Street’s expectations, but the market responded negatively, reflecting concerns beyond the headline numbers. Management attributed the quarter’s performance to robust growth in intelligence and digital infrastructure segments and cited strong demand for advanced defense products such as the AGM-190A missile and unmanned surface vehicles. CEO Thomas Bell emphasized that Leidos’ ability to scale new AI-driven solutions across its five growth pillars—including managed health and energy resilience—was central to the quarter’s revenue gains. However, management also noted that profitability in the Defense segment was tempered by early-stage development programs and ongoing fixed price contract pressures.

Is now the time to buy LDOS? Find out in our full research report (it’s free for active Edge members).

Leidos (LDOS) Q1 CY2026 Highlights:

  • Revenue: $4.4 billion vs analyst estimates of $4.28 billion (3.7% year-on-year growth, 2.8% beat)
  • Adjusted EPS: $3.13 vs analyst estimates of $2.91 (7.6% beat)
  • Adjusted EBITDA: $614 million vs analyst estimates of $581.7 million (14% margin, 5.6% beat)
  • The company lifted its revenue guidance for the full year to $18.2 billion at the midpoint from $17.7 billion, a 2.8% increase
  • Management slightly raised its full-year Adjusted EPS guidance to $12.30 at the midpoint
  • Operating Margin: 11.5%, in line with the same quarter last year
  • Backlog: $48.37 billion at quarter end, up 4.5% year on year
  • Market Capitalization: $16.06 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Leidos’s Q1 Earnings Call

  • Sheila Kahyaoglu (Jefferies) asked about Defense segment profitability and the impact of fixed price programs; CFO Chris Cage explained margin pressure was due to early-stage development but expects improvement as new programs ramp up.
  • Joshua Korn (Wells Fargo) inquired about capital expenditures; CEO Thomas Bell confirmed elevated CapEx is temporary and tied to production scaling, with disciplined spending based on program triggers.
  • Tobey Sommer (Truist Securities) asked about the outlook for the Health business and margin sustainability; Bell emphasized strong volumes and new digital health awards, while Cage expects margins to remain above 20% due to operational efficiencies.
  • Scott Mikus (Melius Research) questioned portfolio complexity and streamlining; Bell stated recent reorganization and appointment of a Defense COO will drive better execution, with a focus on scaling core offerings rather than broad diversification.
  • Kenneth Herbert (RBC Capital Markets) sought an update on Entrust integration and customer reception; Bell reported seamless cultural integration, positive customer feedback, and noted the energy services pipeline should drive rapid growth in coming quarters.

Catalysts in Upcoming Quarters

In the next few quarters, the StockStory team will watch (1) the pace at which new defense and energy infrastructure contracts convert to revenue, (2) margin stabilization as recent investments and acquisitions are integrated, and (3) continued progress in scaling AI-enabled solutions across managed health and digital segments. The ability to execute on portfolio realignment and monitor capital discipline will also be important markers of success.

Leidos currently trades at $128.03, down from $148.81 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  264.23
-4.76 (-1.77%)
AAPL  294.59
+1.91 (0.65%)
AMD  437.92
-20.87 (-4.55%)
BAC  51.02
+0.48 (0.94%)
GOOG  381.69
-5.08 (-1.31%)
META  599.56
+0.70 (0.12%)
MSFT  408.33
-4.33 (-1.05%)
NVDA  220.26
+0.82 (0.38%)
ORCL  184.85
-8.99 (-4.64%)
TSLA  433.02
-11.98 (-2.69%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.